Strides Shasun to acquire Perrigo’s US FDA approved API facility in India
Strides Shasun will acquire 100 per cent of the issued capital of Perrigo API India for a consideration of Rs 1000 million
Author
Prima Nature Care launches sea buckthorn-based phyto-medicines in India
The clinical trials of phyto-medicine have shown remarkable improvements in the conditions of patients with various diseases like…
Biocon features in Asia IP Elite 2016 list
Biocon has built its credibility as an innovation-led enterprise through a track record of IP value creation in discovery,…
Indian pharma industry facing growth headwinds: ICRA
Increasing penetration, accessibility and continued new launches will help Indian pharma industry to grow in the long term
Cipla receives final approval for generic Baraclude tablets
Entecavir tablets are indicated for the treatment of chronic Hepatitis B virus infection
Vacsera (Egyvet) in contract with Fabtech Technologies
The $19 million project will produce 400 million doses of the bird flu vaccine
Lupin receives US FDA approval for generic Topicort ointment
It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Alembic Pharma gets US FDA nod
Zolmitriptan orally disintegrating tablets are used for the treatment of migraine